Cargando…

Association between red blood cell distribution width and the prognosis of brain death in patients with a Glasgow Coma Scale < 6

Red blood cell distribution width (RDW) has been reported as a meaningful prognostic factor in various diseases. Our study compared patients’ RDW levels and prognosis at admission and discharge time. A total of 128 patients 77 patients who suffered brain death (subject group), and 51 patients who we...

Descripción completa

Detalles Bibliográficos
Autores principales: Latifi, Marzieh, Rahban, Habib, Pourhosein, Elahe, Shostak, Daniel, Dehghani, Sanaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462613/
https://www.ncbi.nlm.nih.gov/pubmed/37640749
http://dx.doi.org/10.1038/s41598-023-39836-6
_version_ 1785098069500493824
author Latifi, Marzieh
Rahban, Habib
Pourhosein, Elahe
Shostak, Daniel
Dehghani, Sanaz
author_facet Latifi, Marzieh
Rahban, Habib
Pourhosein, Elahe
Shostak, Daniel
Dehghani, Sanaz
author_sort Latifi, Marzieh
collection PubMed
description Red blood cell distribution width (RDW) has been reported as a meaningful prognostic factor in various diseases. Our study compared patients’ RDW levels and prognosis at admission and discharge time. A total of 128 patients 77 patients who suffered brain death (subject group), and 51 patients who were discharged from the hospital (control group) with GCS ≤ 6 were recruited from 60 hospitals for this study. Demographical data and RDW measurements in these patients at admission time and brain death/discharge time were extracted into two groups. 46 (35.9%) patients were females and 82 patients (64.1%) were males with a median age of 36 years old. A significant difference in baseline characteristics of GCS (P < 0.001), RDW at admission time (P < 0.001), and RDW at discharge or brain death time (P < 0.001) were noted between the two groups. In the overall population, RDW at admission time had a median value of 13.75% and was positively correlated with gender (P < 0.04, rs = 0.582) and age (P < 0.023, rs = − 0.201). Initially, there were no significant differences in RDW upon admission. However, upon discharge, although the RDW in the control group was not significant (P < 0. 1), the RDW level at the time of brain death was notably 0.45 fold higher (P = 0.001) compared to the time of admission. The standardized residuals at the two-time points showed an approximately normal distribution. The most effective RDW cut-off in Brain death was determined as 14.55. Based on the findings, using RDW as a prognostic factor has a sensitivity of 0.468 and a specificity of 0.137 in diagnosing brain death. RDW biomarker is a simple and inexpensive laboratory test that may be seen as a valuable perspective for initial patient evaluation. RDW is a powerful marker for the prognosis of brain death in patients with a GCS ≤ 6 at admission time, in order to identify a subset of patients who may require more aggressive management in the trauma center.
format Online
Article
Text
id pubmed-10462613
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-104626132023-08-30 Association between red blood cell distribution width and the prognosis of brain death in patients with a Glasgow Coma Scale < 6 Latifi, Marzieh Rahban, Habib Pourhosein, Elahe Shostak, Daniel Dehghani, Sanaz Sci Rep Article Red blood cell distribution width (RDW) has been reported as a meaningful prognostic factor in various diseases. Our study compared patients’ RDW levels and prognosis at admission and discharge time. A total of 128 patients 77 patients who suffered brain death (subject group), and 51 patients who were discharged from the hospital (control group) with GCS ≤ 6 were recruited from 60 hospitals for this study. Demographical data and RDW measurements in these patients at admission time and brain death/discharge time were extracted into two groups. 46 (35.9%) patients were females and 82 patients (64.1%) were males with a median age of 36 years old. A significant difference in baseline characteristics of GCS (P < 0.001), RDW at admission time (P < 0.001), and RDW at discharge or brain death time (P < 0.001) were noted between the two groups. In the overall population, RDW at admission time had a median value of 13.75% and was positively correlated with gender (P < 0.04, rs = 0.582) and age (P < 0.023, rs = − 0.201). Initially, there were no significant differences in RDW upon admission. However, upon discharge, although the RDW in the control group was not significant (P < 0. 1), the RDW level at the time of brain death was notably 0.45 fold higher (P = 0.001) compared to the time of admission. The standardized residuals at the two-time points showed an approximately normal distribution. The most effective RDW cut-off in Brain death was determined as 14.55. Based on the findings, using RDW as a prognostic factor has a sensitivity of 0.468 and a specificity of 0.137 in diagnosing brain death. RDW biomarker is a simple and inexpensive laboratory test that may be seen as a valuable perspective for initial patient evaluation. RDW is a powerful marker for the prognosis of brain death in patients with a GCS ≤ 6 at admission time, in order to identify a subset of patients who may require more aggressive management in the trauma center. Nature Publishing Group UK 2023-08-28 /pmc/articles/PMC10462613/ /pubmed/37640749 http://dx.doi.org/10.1038/s41598-023-39836-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Latifi, Marzieh
Rahban, Habib
Pourhosein, Elahe
Shostak, Daniel
Dehghani, Sanaz
Association between red blood cell distribution width and the prognosis of brain death in patients with a Glasgow Coma Scale < 6
title Association between red blood cell distribution width and the prognosis of brain death in patients with a Glasgow Coma Scale < 6
title_full Association between red blood cell distribution width and the prognosis of brain death in patients with a Glasgow Coma Scale < 6
title_fullStr Association between red blood cell distribution width and the prognosis of brain death in patients with a Glasgow Coma Scale < 6
title_full_unstemmed Association between red blood cell distribution width and the prognosis of brain death in patients with a Glasgow Coma Scale < 6
title_short Association between red blood cell distribution width and the prognosis of brain death in patients with a Glasgow Coma Scale < 6
title_sort association between red blood cell distribution width and the prognosis of brain death in patients with a glasgow coma scale < 6
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462613/
https://www.ncbi.nlm.nih.gov/pubmed/37640749
http://dx.doi.org/10.1038/s41598-023-39836-6
work_keys_str_mv AT latifimarzieh associationbetweenredbloodcelldistributionwidthandtheprognosisofbraindeathinpatientswithaglasgowcomascale6
AT rahbanhabib associationbetweenredbloodcelldistributionwidthandtheprognosisofbraindeathinpatientswithaglasgowcomascale6
AT pourhoseinelahe associationbetweenredbloodcelldistributionwidthandtheprognosisofbraindeathinpatientswithaglasgowcomascale6
AT shostakdaniel associationbetweenredbloodcelldistributionwidthandtheprognosisofbraindeathinpatientswithaglasgowcomascale6
AT dehghanisanaz associationbetweenredbloodcelldistributionwidthandtheprognosisofbraindeathinpatientswithaglasgowcomascale6